Capital Fund Management S.A. Grows Stock Holdings in Silicon Laboratories, Inc. $SLAB

Key Points

• Capital Fund Management S.A. increased its holdings in Silicon Laboratories, Inc. by 8.3%, acquiring an additional 3,821 shares and bringing its total ownership to 49,895 shares valued at $5.62 million.
• Silicon Laboratories reported a quarterly EPS of $0.11, surpassing estimates, with a revenue of $192.85 million, a 32.6% year-over-year increase.
• Analysts have issued mixed ratings on SLAB, with a consensus target price of $151.13 and five analysts rating it as a "Buy".

Capital Fund Management S.A. boosted its stake in shares of Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) by 8.3% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 49,895 shares of the semiconductor company's stock after purchasing an additional 3,821 shares during the period. Capital Fund Management S.A. owned approximately 0.15% of Silicon Laboratories worth $5,617,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in SLAB. Skandinaviska Enskilda Banken AB publ acquired a new stake in shares of Silicon Laboratories during the 1st quarter valued at about $34,000. UMB Bank n.a. raised its holdings in Silicon Laboratories by 111.3% in the 1st quarter. UMB Bank n.a. now owns 336 shares of the semiconductor company's stock worth $38,000 after purchasing an additional 177 shares during the period. Parallel Advisors LLC raised its holdings in Silicon Laboratories by 143.7% in the 1st quarter. Parallel Advisors LLC now owns 463 shares of the semiconductor company's stock worth $52,000 after purchasing an additional 273 shares during the period. Larson Financial Group LLC acquired a new position in Silicon Laboratories in the 1st quarter worth about $55,000. Finally, Caitong International Asset Management Co. Ltd acquired a new position in Silicon Laboratories in the 1st quarter worth about $77,000.

Insider Transactions at Silicon Laboratories

In other news, SVP Brandon Tolany sold 8,000 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $145.23, for a total transaction of $1,161,840.00. Following the completion of the sale, the senior vice president owned 62,328 shares in the company, valued at approximately $9,051,895.44. This represents a 11.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.60% of the stock is owned by corporate insiders.

Silicon Laboratories Stock Down 0.1%

Shares of Silicon Laboratories stock traded down $0.20 on Thursday, hitting $139.47. 86,991 shares of the company were exchanged, compared to its average volume of 403,762. The stock has a market capitalization of $4.58 billion, a price-to-earnings ratio of -43.27 and a beta of 1.48. The company has a 50-day moving average price of $139.05 and a 200 day moving average price of $127.83. Silicon Laboratories, Inc. has a 1-year low of $82.82 and a 1-year high of $160.00.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.02. The business had revenue of $192.85 million for the quarter, compared to analyst estimates of $192.57 million. Silicon Laboratories had a negative return on equity of 7.21% and a negative net margin of 14.88%.The company's revenue was up 32.6% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.56) earnings per share. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. Research analysts forecast that Silicon Laboratories, Inc. will post -0.97 EPS for the current year.

Analysts Set New Price Targets

A number of research firms recently weighed in on SLAB. Needham & Company LLC reaffirmed a "buy" rating and issued a $150.00 price target on shares of Silicon Laboratories in a report on Wednesday, May 14th. Barclays upped their price target on Silicon Laboratories from $100.00 to $130.00 and gave the stock an "equal weight" rating in a report on Tuesday, August 5th. Benchmark reaffirmed a "buy" rating and issued a $160.00 price target on shares of Silicon Laboratories in a report on Tuesday, May 27th. Stifel Nicolaus lifted their price objective on Silicon Laboratories from $144.00 to $160.00 and gave the stock a "buy" rating in a report on Friday, July 18th. Finally, Susquehanna lifted their price objective on Silicon Laboratories from $110.00 to $150.00 and gave the stock a "neutral" rating in a report on Tuesday, July 22nd. Five equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $151.13.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.